Defining and characterizing the critical transition state prior to the type 2 diabetes disease

• Bo Jin ,

  Contributed equally to this work with: Bo Jin, Rui Liu, Shiying Hao, Zhen Li

  Affiliation HBI Solutions Inc., Palo Alto, California, United States of America

  ⨯
• Rui Liu ,

  Contributed equally to this work with: Bo Jin, Rui Liu, Shiying Hao, Zhen Li

  Affiliations Stanford University, Stanford, California, United States of America, School of Mathematics, South China University of Technology, Guangzhou, China

  ⨯
• Shiying Hao ,

  Contributed equally to this work with: Bo Jin, Rui Liu, Shiying Hao, Zhen Li

  Affiliations Stanford University, Stanford, California, United States of America, Clinical and Translational Research Program, Betty Irene Moore Children's Heart Center, Lucile Packard Children’s Hospital, Stanford, California, United States of America

  ⨯
• Zhen Li ,

  Contributed equally to this work with: Bo Jin, Rui Liu, Shiying Hao, Zhen Li

  Affiliations Stanford University, Stanford, California, United States of America, School of Electrical Engineering, Southeast University, Nanjing, China

  ⨯
• Chunqing Zhu,

  Affiliation HBI Solutions Inc., Palo Alto, California, United States of America

  ⨯
• Xin Zhou,

  Affiliation Tianjin Key Laboratory of Cardiovascular Remodeling and Target Organ Injury, Pingjin Hospital Heart Center, Tianjin, China

  ⨯
• Pei Chen,

  Affiliation School of Computer Science and Engineering, South China University of Technology, Guangzhou, China

  ⨯
• Tianyun Fu,

  Affiliation HBI Solutions Inc., Palo Alto, California, United States of America

  ⨯
• Zhongkai Hu,

  Affiliation Stanford University, Stanford, California, United States of America

  ⨯
• Qian Wu,

  Affiliation China Electric Power Research Institute, Beijing, China

  ⨯
• Wei Liu,

  Affiliation China Electric Power Research Institute, Beijing, China

  ⨯
• Daowei Liu,

  Affiliation China Electric Power Research Institute, Beijing, China

  ⨯
• Yunxian Yu,

  Affiliation School of Medicine, Zhejiang University, Hangzhou, China

  ⨯
• Yan Zhang,

  Affiliations Stanford University, Stanford, California, United States of America, Department of Oncology, the First Hospital of Shijiazhuang, Shijiazhuang, Hebei, China

  ⨯
• Doff B. McElhinney,

  Affiliations Stanford University, Stanford, California, United States of America, Clinical and Translational Research Program, Betty Irene Moore Children's Heart Center, Lucile Packard Children’s Hospital, Stanford, California, United States of America

  ⨯
• Yu-Ming Li,

  Affiliation Tianjin Key Laboratory of Cardiovascular Remodeling and Target Organ Injury, Pingjin Hospital Heart Center, Tianjin, China

  ⨯
• Devore S Culver,

  Affiliation HealthInfoNet, Portland, Maine, United States of America

  ⨯
• Shaun T. Alfreds,

  Affiliation HealthInfoNet, Portland, Maine, United States of America

  ⨯
• Frank Stearns,

  Affiliation HBI Solutions Inc., Palo Alto, California, United States of America

  ⨯
• Karl G. Sylvester,

  Affiliation Stanford University, Stanford, California, United States of America

  ⨯
• Eric Widen,

  Affiliation HBI Solutions Inc., Palo Alto, California, United States of America

  ⨯
•  [ ... ],
• Xuefeng B. Ling

  * E-mail: bxling@stanford.edu

  Affiliations Stanford University, Stanford, California, United States of America, Clinical and Translational Research Program, Betty Irene Moore Children's Heart Center, Lucile Packard Children’s Hospital, Stanford, California, United States of America, Health Care Big Data Center, School of Public Health, Zhejiang University, Hangzhou, China

  http://orcid.org/0000-0002-5386-3884

  ⨯
• [ view all ]
• [ view less ]